A population-based case-control study of oral chlordiazepoxide use during pregnancy and risk of congenital abnormalities

Neurotoxicology and Teratology

Volumn 26, Issue 4, 2004, Pages 593-598

  Czeizel, A E ^a   Rockenbauer, M ^b   Sorensen H T ^c   Olsen, J ^c,d  

^a Found Comm Contr of Hered Dis   (Hungary)

^b NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

Author keywords

Cardiovascular malformations; Case control analysis; Chlordiazepoxide; Congenital abnormalities; Human teratogenic effect

Indexed keywords

CHLORDIAZEPOXIDE;

ARTICLE; CARDIOVASCULAR MALFORMATION; CONFIDENCE INTERVAL; CONGENITAL MALFORMATION; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; GESTATIONAL AGE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MOTHER; NEWBORN; POPULATION RESEARCH; PREGNANCY; PRIORITY JOURNAL; RISK ASSESSMENT; SELF REPORT; TERATOGENESIS;

ABNORMALITIES, DRUG-INDUCED; ADMINISTRATION, ORAL; ANTI-ANXIETY AGENTS; CASE-CONTROL STUDIES; CHLORDIAZEPOXIDE; CONFOUNDING FACTORS (EPIDEMIOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; MATCHED-PAIR ANALYSIS; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 2942661563     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2004.03.009     Document Type: Article

References (25)

1. Bergman U., Rosa F.W., Baum C., Wiholm B.-E., Faich G.A. Effects of exposure to benzodiazepine during fetal life. Lancet. 340:1992;694-696
2. Bracken M.B., Holford T.R. Exposure to prescribed drugs in pregnancy and association with congenital malformations. Obstet. Gynecol. 58:1981;336-344
3. Buttar H.S. Effects of chlordiazepoxide on the pre- and postnatal development of rats. Toxicology. 17:1980;311-321
4. Crombie D.L., Pinsent R.J., Fleming D.M., Rumeau-Rouguette C., Goujard J., Huel G. Fetal effects of tranquilizers in pregnancy. N. Engl. J. Med. 293:1975;198-199
5. Czeizel A.E. Lack of evidence of teratogenicity of benzodiazepine drugs in Hungary. Reprod. Toxicol. 1:1988;183-188
6. Czeizel A.E. The first 25 years of the Hungarian Congenital Abnormality Registry. Teratology. 55:1997;299-305
7. Czeizel A.E. The role of pharmacoepidemiology in pharmacovigilance: rational drug use in pregnancy. Pharmacoepidemiol. Drug Saf. 8:1999;S55-S61
8. Czeizel A.E., Telegdi L., Tusnády G. Multiple Congenital Abnormalities. 1988;Akadémiai Kiadó Budapest
9. Czeizel A.E., Rockenbauer M., Siffel C.s., Varga E. Description and mission evaluation of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980-1996. Teratology. 63:2001;176-185
10. Czeizel A.E., Petik D., Vargha P. Validation studies of drug exposures in pregnant women. Pharmacoepidemiol. Drug Saf. 12:2003;409-416
11. Friedman J.M., Polifka J.E. The Effects of Drugs on the Fetus and Nursing Infant. 1996;Johns Hopkins Univ. Press, Baltimore
12. Guram M.S., Gill T.S., Geber W.F. Comparative teratogenicity of chlordiazepoxide, amitriptyline, and a combination of the two compounds in the fetal hamster. Neurotoxicology. 3:1982;83-90
13. Hartz S.C., Heinonen O.P., Shapiro S., Siskind V., Slone D. Antenatal exposure to mepbromate and chlordiazepoxide in relation to malformations, mental development and childhood mortality. N. Engl. J. Med. 292:1975;726-728
14. Heinonen O.P., Slone D., Shapiro S. Birth Defects and Drugs in Pregnancy. 1977;Publ. Sciences Group, Littleton, MA
15. Kanto J.H. Use of benzodiazepines during pregnancy, labour and lactation, with particular reference to pharmacokinetic considerations. Drugs. 23:1982;354-380
16. Kanto J., Erkkola R., Sellman R. Accumulation of diazepam and n-demethyldiazepam in the fetal blood during labor. Ann. Clin. Res. 5:1973;375-379
17. Kullander S., Källen B. A prospective study of drugs and pregnancy: I. Psychopharmaca. Acta Obstet. Gynecol. Scand. 55:1976;25-33
18. Milkovich L., van der Bergh B.J. Effects of prenatal meprobromate and chlordiazepoxide hydrochloride on human embryonic and fetal development. N. Engl. J. Med. 291:1974;1268-1271
19. Rockenbauer M., Olsen J., Czeizel A.E., Pedersen L., Sørensen H.T. EuroMap Group Recall bias in a case-control study on the use of medicine during pregnancy. Epidemiology. 12:2001;401-466
20. F. Rosa, 1993. cit. Briggs, G.G., Freeman, R.K., Yaffe, S.J.: Drugs in Pregnancy and Lactation, 5th ed., Williams and Wilkins, Baltimore, 1998.
21. Rothman K.J., Fyler D.C., Goldblatt A., Kreidberg M.B. Exogenous hormones and other drug exposures of children with congenital heart disease. Am. J. Epidemiol. 109:1979;433-439
22. Saito H., Kobayashi T., Takeno S., Sakai T. Fetal toxicity of benzodiazepines in rats. Res. Commun. Chem. Pathol. Pharmacol. 46:1984;437-447
23. Stata Corp. STATA Statistical Software: Release 4.0 for Windows. 1997;Stata, College Station, TX
24. Stirrat G.M., Edington P.T., Berry D.J. Transplacental passage of chlordiazepoxide. Br. Med. J. 2:1974;729
25. Usdin E., Skolnick P., Tallman J.F. Jr. Pharmacology of Benzodiazepines. 1982;Macmillan, London